Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial.
Publication
, Journal Article
Swartz, MS; Perkins, DO; Stroup, TS; McEvoy, JP; Nieri, JM; Haak, DC
Published in: Schizophr Bull
2003
Schizophrenia is a symptomatically heterogeneous disorder characterized by the presence of positive and negative symptoms, and variable impairment in community functioning. Given the diversity of symptom presentations and functioning associated with schizophrenia, one of the key challenges facing the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial was the selection of efficient assessment measures appropriate to a community-based effectiveness trial. This article describes the rationale for the measurement approach adopted for the trial, provides a brief overview of the selected measures, and describes the process of training assessment raters for a large and geographically dispersed study group.
Duke Scholars
Published In
Schizophr Bull
DOI
ISSN
0586-7614
Publication Date
2003
Volume
29
Issue
1
Start / End Page
33 / 43
Location
United States
Related Subject Headings
- Surveys and Questionnaires
- Substance-Related Disorders
- Schizophrenia
- Quality of Life
- Psychomotor Agitation
- Psychiatry
- Outcome and Process Assessment, Health Care
- Life Style
- Humans
- Diagnostic and Statistical Manual of Mental Disorders
Citation
APA
Chicago
ICMJE
MLA
NLM
Swartz, M. S., Perkins, D. O., Stroup, T. S., McEvoy, J. P., Nieri, J. M., & Haak, D. C. (2003). Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial. Schizophr Bull, 29(1), 33–43. https://doi.org/10.1093/oxfordjournals.schbul.a006989
Swartz, Marvin S., Diana O. Perkins, T Scott Stroup, Joseph P. McEvoy, Jennifer M. Nieri, and David C. Haak. “Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial.” Schizophr Bull 29, no. 1 (2003): 33–43. https://doi.org/10.1093/oxfordjournals.schbul.a006989.
Swartz MS, Perkins DO, Stroup TS, McEvoy JP, Nieri JM, Haak DC. Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial. Schizophr Bull. 2003;29(1):33–43.
Swartz, Marvin S., et al. “Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial.” Schizophr Bull, vol. 29, no. 1, 2003, pp. 33–43. Pubmed, doi:10.1093/oxfordjournals.schbul.a006989.
Swartz MS, Perkins DO, Stroup TS, McEvoy JP, Nieri JM, Haak DC. Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial. Schizophr Bull. 2003;29(1):33–43.
Published In
Schizophr Bull
DOI
ISSN
0586-7614
Publication Date
2003
Volume
29
Issue
1
Start / End Page
33 / 43
Location
United States
Related Subject Headings
- Surveys and Questionnaires
- Substance-Related Disorders
- Schizophrenia
- Quality of Life
- Psychomotor Agitation
- Psychiatry
- Outcome and Process Assessment, Health Care
- Life Style
- Humans
- Diagnostic and Statistical Manual of Mental Disorders